Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/1670| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Marica Pavkovic | en_US |
| dc.contributor.author | Aleksandar Petlichkovski | en_US |
| dc.contributor.author | Oliver Karanfilski | en_US |
| dc.contributor.author | Lidija Cevreska | en_US |
| dc.contributor.author | Aleksandar Stojanovic | en_US |
| dc.date.accessioned | 2019-03-12T12:43:12Z | - |
| dc.date.available | 2019-03-12T12:43:12Z | - |
| dc.date.issued | 2018-04 | - |
| dc.identifier.uri | http://hdl.handle.net/20.500.12188/1670 | - |
| dc.description.abstract | Immune thrombocytopenia (ITP) is an autoimmune blood disease of unknown etiology. The aim of our study was to investigate a possible role of FCGR2A and FCGR3A polymorphisms in the development of primary ITP. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Taylor & Francis | en_US |
| dc.relation.ispartof | Hematology | en_US |
| dc.title | FC gamma receptor polymorphisms in patients with immune thrombocytopenia | en_US |
| dc.type | Article | en_US |
| dc.identifier.doi | 10.1080/10245332.2017.1377902 | - |
| dc.identifier.url | https://www.tandfonline.com/doi/pdf/10.1080/10245332.2017.1377902 | - |
| dc.identifier.volume | 23 | - |
| dc.identifier.issue | 3 | - |
| dc.identifier.fpage | 163 | - |
| dc.identifier.lpage | 168 | - |
| item.grantfulltext | none | - |
| item.fulltext | No Fulltext | - |
| crisitem.author.dept | Faculty of Medicine | - |
| crisitem.author.dept | Faculty of Medicine | - |
| crisitem.author.dept | Faculty of Medicine | - |
| crisitem.author.dept | Faculty of Medicine | - |
| Appears in Collections: | Faculty of Medicine: Journal Articles | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.